Key result
Labetalol effectively controls delayed post-ECT and essential hypertension refractory to clonidine and hydralazine.
Why the study?
Does intravenous and oral labetalol effectively manage delayed post-electroconvulsive therapy hypertension refractory to clonidine and hydralazine?
Case Report (n=1)
Does intravenous and oral labetalol effectively manage delayed post-electroconvulsive therapy hypertension refractory to clonidine and hydralazine?
Both intravenous and oral labetalol may effectively manage delayed hypertension induced by electroconvulsive therapy when clonidine and hydralazine are inadequate.
Answers are grounded in this paper and cite their sources.
Labetalol may control refractory post-ECT hypertension; this Level 5 case leaves open its broader role and does not support practice change.
A 74-year-old woman with essential hypertension underwent a course of electroconvulsive therapy (ECT) for the treatment of psychotic depression. Her treatments were associated with delayed and significant hypertension. Clonidine, which controlled her baseline blood pressure, was inadequate in treating her post-ECT hypertension. Acute treatment with hydralazine also failed. Labetalol, a short-acting beta-blocking agent with some alpha-1 blocking activity, worked well both acutely (intravenously) and orally to manage essential and ECT-induced hypertension.
No takes yet. Share an insight, caveat, or question.
FOSTER et al. (1988) conducted a case report in Essential and electroconvulsive therapy (ECT)-induced delayed hypertension in a patient with psychotic depression (n=1). Labetalol (intravenous and oral) vs. Clonidine and acute hydralazine was evaluated on Control of essential and delayed post-ECT hypertension. Labetalol (IV and oral) effectively managed delayed post-ECT and essential hypertension in 1 patient (74-year-old woman) after clonidine and hydralazine failed.
Synapse has enriched 10 related papers. Consider them for comparative context: